1,752 results on '"BIFFI, MAURO"'
Search Results
202. Industry Pulse
203. Outcome of cardioverter–defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy
204. Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization
205. Rate control in patients with pacemaker affected by brady-tachy form of sick sinus syndrome
206. Implantable Dual-Chamber Defibrillator for the Selective Treatment of Spontaneous Atrial and Ventricular Arrhythmias: Arrhythmia Incidence and Device Performance
207. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy: the resynchronization for the hemodynamic trreatment for heart failure management II implantable cardioverster defibrillator (RHYTHM II ICD) study
208. Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy
209. Hybrid transcatheter left ventricular reconstruction for the treatment of ischemic cardiomyopathy
210. The value of ECG changes in risk stratification of COVID‐19 patients
211. Cardiac Stimulation in the Third Millennium: Where Do We Head from Here?
212. Pharmacological Cardioversion of Atrial Fibrillation: Current Management and Treatment Options
213. Pacing devices to treat bradycardia: current status and future perspectives
214. Clinical impact of defibrillation testing in a real‐world S‐ICD population: Data from the ELISIR registry
215. Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering
216. Rate Control in Atrial Fibrillation: Choice of Treatment and Assessment of Efficacy
217. From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction
218. Left ventricular pacing rate lower than expected during manual pacing threshold test in a biventricular defibrillator
219. Response to the Letter from Dr Bertini
220. Occurrence of phrenic nerve stimulation in cardiac resynchronization therapy patients: the role of left ventricular lead type and placement site
221. A randomised cross-over study on the haemodynamic effects of oral dofetilide compared with oral sotalol in patients with ischaemic heart disease and sustained ventricular tachycardia
222. Oral Loading with Propafenone for Conversion of Recent-Onset Atrial Fibrillation: A Review on In-Hospital Treatment
223. Cost-effectiveness of cardiac resynchronisation therapy
224. Neurocardiogenic Syncope in Selected Pediatric Patients—Natural History during Long-Term Follow-Up and Effect of Prophylactic Pharmacological Therapy
225. Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients
226. Electrocardiographic remodeling during cardiac resynchronization therapy
227. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy: The Resynchronization for the Hemod Ynamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study
228. Transvenous internal cardioversion for atrial fibrillation: a randomized comparison between catheters with different coil length
229. Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations
230. Impact of Mitral Regurgitation on the Outcome of Patients Treated with CRT-D: Data from the InSync ICD Italian Registry
231. Atrial Fibrillation: It Is Better to Be Alone Than in Bad Company!
232. Cardiac resynchronization therapy in heart failure: Doubts and certainties
233. Evaluation of Atrial Refractoriness and Atrial Fibrillation Inducibility Immediately after Internal Cardioversion in Patients with Chronic Persistent Atrial Fibrillation
234. Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ?
235. Clinical Management of Atrial Fibrillation: Need for a Comprehensive Patient-Centered Approach
236. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy
237. Improving Stroke Risk Stratification Using the CHADS2 and CHA2DS2-VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden Monitoring
238. Excimer laser lead extraction by femoral approach
239. Cardiac resynchronization therapy: a cost or an investment?
240. Response
241. From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter–defibrillator systems
242. Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction
243. Long-Term RV Threshold Behavior by Automated Measurements: Safety is the Standpoint of Pacemaker Longevity!
244. The Challenge of Preventing Stroke in Elderly Patients With Atrial Fibrillation
245. Prevention of long‐lasting atrial fibrillation through antitachycardia pacing in DDDR pacemakers
246. Abstract 15562: Incidence and Risk Factors of Device-related Infection in De Novo Transvenous Implantable Cardiac Defibrillator Medicare Patients
247. Long-term percentage of ventricular pacing in patients requiring pacemaker implantation after transcatheter aortic valve replacement: A multicenter 10-year experience
248. Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study
249. Cost-effectiveness of cardiac resynchronization therapy
250. Risk of syncopal recurrences in patients treated with permanent pacing for bradyarrhythmic syncope: role of correlation between symptoms and electrocardiogram findings
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.